Commentary
Podcast
ESG Evolution
Author(s):
In this PC Podcast episode, Susanne Katus discusses the increasing number of regulations impacting both pharma and biotech companies.
In this exclusive PC Podcast interview, Susanne Katus, SVP, market leader, corporate secretary at Datamaran, a platform that monitors and analyzes risk factors, dives into:
- The growing number of environmental, social, and governance (ESG) regulations impacting these aforementioned businesses
- Where the responsibility lies for them in terms of ESG compliance
- What can be done in order for these corporations to be ahead of the game
- Why ESG should be a top priority
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Related Videos
Related Content
